International Conference on

Cancer Therapy

Osaka, Japan   July 23-24, 2018

Eric Raymond

Eric Raymond

Paris Saint Joseph Hospital


Prof. Eric Raymond, M.D., Ph.D. serves as Consultant of Erytech Pharma Société Anonyme. Prof. Raymond serves as a Consultant of Preclinical and Translational Research France of Cvitkovic & Associés Consultants S.A and AAI Oncology. Prof. Raymond has been Member of Scientific Advisory Board at PharmaEngine, Inc. since January 2017. He has been a Member of Scientific Board of Erytech Pharma Société Anonyme (formerly, ERYtech Pharma SA) since October 30, 2009. He serves as a Member of the Scientific Board of Manros Therapeutics. He is the Head of Medical Oncology at Paris Saint-Joseph Hospital Group. Prof. Raymond is a Professor of Medical Oncology at the University Paris VII (Denis Diderot) and Head of the Department of Medical Oncology (Service Inter Hospitalier de Cancérologie) at Bichat-Beaujon University Hospitals in Paris. He serves as consultant in medical oncology at Bichat Hospital. He was the Principal Investigator of less than 50 clinical trials, including phase I, II and III studies. Some of his works were seminal in the development of phase III trials and registration of some drugs such as oxaliplatin, sunitinib, temsirolimus and everolimus. He has highly regarded expertise in Oncology in clinical and pre-clinical approaches. He has published more than 100 articles and is a member of several international societies of experts in the field of oncology. Prof. Raymond received his M.D. and Ph.D. from Pierre et Marie Curie Paris 6 University, France.

Research Interest

Medical Oncology Immunotherapy Targeted therapy

Related Conferenes